rxstat › Shortages › Dabigatran Etexilate

Dabigatran Etexilate shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Dabigatran Etexilate products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 12, 2026.
Products affected
2 / 6
In shortage since
Oct 22, 2024
Est. full return
Jun 12, 2026
Reports on file
30
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-DABIGATRAN
110MG · CAPSULE · APOTEX INC
DIN 02468905 · since Apr 14, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DABIGATRAN
110MG · CAPSULE · APOTEX INC
DIN 02468905 · since Nov 12, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-DABIGATRAN
150MG · CAPSULE · APOTEX INC
DIN 02468913 · since Oct 22, 2024, no end estimate · Disruption of the manufacture of the drug.
Discontinued
PRADAXA
75MG · CAPSULE · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02312433
Resolved
APO-DABIGATRAN
110MG · CAPSULE · APOTEX INC
DIN 02468905 · ended May 22, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
110MG · CAPSULE · APOTEX INC
DIN 02468905 · ended Jan 23, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
150MG · CAPSULE · APOTEX INC
DIN 02468913 · ended Sep 19, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
110MG · CAPSULE · APOTEX INC
DIN 02468905 · ended Sep 19, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
150MG · CAPSULE · APOTEX INC
DIN 02468913 · ended Jul 18, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
75MG · CAPSULE · APOTEX INC
DIN 02468891 · ended Jul 18, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
110MG · CAPSULE · APOTEX INC
DIN 02468905 · ended Feb 22, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DABIGATRAN
150MG · CAPSULE · APOTEX INC
DIN 02468913 · ended Feb 22, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 30 reports. All reports are on file with Health Canada.

What's happening

Dabigatran Etexilate is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Dabigatran Etexilate is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AE).

Recent changes

Common questions

When will Dabigatran Etexilate be back in stock in Canada?

The latest manufacturer estimate is Jun 12, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Dabigatran Etexilate in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageRivaroxaban5 of 18 reported products affected · est. return Nov 30, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.